Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00436618 · BASELINE

Baseline characteristics

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment · Source last updated 2019-10-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      114
    2. group Id
      BG001
      value
      55
    3. group Id
      BG002
      value
      107
    4. group Id
      BG003
      value
      276
    units
    Participants
groups
  1. description
    Study 1. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG000
    title
    Relapsed Aggressive Non-Hodgkin Lymphoma
  2. description
    Study 2. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG001
    title
    Relapsed Indolent Non-Hodgkin Lymphoma
  3. description
    Study 3. Includes Hodgkin's lymphomas. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG002
    title
    Uncommon Lymphomas
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          36
          upper Limit
          92
          value
          70
        2. group Id
          BG001
          lower Limit
          33
          upper Limit
          85
          value
          67
        3. group Id
          BG002
          lower Limit
          20
          upper Limit
          85
          value
          60
        4. group Id
          BG003
          lower Limit
          20
          upper Limit
          92
          value
          66
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          41
        2. group Id
          BG001
          value
          25
        3. group Id
          BG002
          value
          28
        4. group Id
          BG003
          value
          94
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          73
        2. group Id
          BG001
          value
          30
        3. group Id
          BG002
          value
          79
        4. group Id
          BG003
          value
          182
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          114
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          107
        4. group Id
          BG003
          value
          276
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          29
        4. group Id
          BG003
          value
          29
      title
      Hodgkin Lymphoma
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          114
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          78
        4. group Id
          BG003
          value
          247
      title
      Non-Hodgkin Lymphoma
    param Type
    NUMBER
    title
    Hodgkin versus Non-Hodgkin Lymphoma
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      114
    2. group Id
      BG001
      value
      55
    3. group Id
      BG002
      value
      107
    4. group Id
      BG003
      value
      276
    units
    Participants
groups
  1. description
    Study 1. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG000
    title
    Relapsed Aggressive Non-Hodgkin Lymphoma
  2. description
    Study 2. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG001
    title
    Relapsed Indolent Non-Hodgkin Lymphoma
  3. description
    Study 3. Includes Hodgkin's lymphomas. Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time. Everolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.
    id
    BG002
    title
    Uncommon Lymphomas
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          36
          upper Limit
          92
          value
          70
        2. group Id
          BG001
          lower Limit
          33
          upper Limit
          85
          value
          67
        3. group Id
          BG002
          lower Limit
          20
          upper Limit
          85
          value
          60
        4. group Id
          BG003
          lower Limit
          20
          upper Limit
          92
          value
          66
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          41
        2. group Id
          BG001
          value
          25
        3. group Id
          BG002
          value
          28
        4. group Id
          BG003
          value
          94
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          73
        2. group Id
          BG001
          value
          30
        3. group Id
          BG002
          value
          79
        4. group Id
          BG003
          value
          182
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          114
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          107
        4. group Id
          BG003
          value
          276
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          29
        4. group Id
          BG003
          value
          29
      title
      Hodgkin Lymphoma
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          114
        2. group Id
          BG001
          value
          55
        3. group Id
          BG002
          value
          78
        4. group Id
          BG003
          value
          247
      title
      Non-Hodgkin Lymphoma
    param Type
    NUMBER
    title
    Hodgkin versus Non-Hodgkin Lymphoma
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice